Access
To read this story in full you will need to login or make a payment (see right).
Brief Communications Arising
Nature 438, E5 (24 November 2005) | doi:10.1038/nature04423; Published online 23 November 2005
Open Innovation Challenges
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
nature jobs
Account Director -India
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Basic Science Medical Educators
- Texas Tech University Health Sciences Center
- El Paso, Texas, USA
Immunology: Insulin auto-antigenicity in type 1 diabetes
Darcy B. Wilson1
Abstract
Arising from: M. Nakayama et al. Nature 435, 220–223 (2005) and S. C. Kent et al. Nature 435, 224–228 (2005); D. A. Hafler et al. reply
Spontaneous type 1 diabetes occurs when the autoimmune destruction of pancreatic
-islet cells prevents production of the hormone insulin. This causes an inability to regulate glucose metabolism, which results in dangerously raised blood glucose concentrations. It is generally accepted that thymus-derived lymphocytes (T cells) are critically involved in the onset and progression of type 1 diabetes, but the antigens that initiate and drive this destructive process remain poorly characterized — although several candidates have been considered1. Nakayama et al.2 and Kent et al.3 claim that insulin itself is the primary autoantigen that initiates spontaneous type 1 diabetes in mice and humans, respectively, a result that could have implications for more effective prevention and therapy. However, I believe that this proposed immunological role of insulin may be undermined by the atypical responses of T cells to the human insulin fragment that are described by Kent et al.3.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Prime role for an insulin epitope in the development of type 1 diabetes in NOD miceNature Letters to Editor (12 May 2005)
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83?99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligandNature Medicine Article (01 Oct 2000)
Immunology Insulin auto-antigenicity in type 1 diabetes (Reply)Nature Brief Communication (24 Nov 2005)

